Acute Exacerbation of Rheumatoid Arthritis Misdiagnosed as COVID-19: A Case Report.
COVID-19
diagnosis
interstitial lung disease
misdiagnosis
rheumatoid arthritis
Journal
Frontiers in medicine
ISSN: 2296-858X
Titre abrégé: Front Med (Lausanne)
Pays: Switzerland
ID NLM: 101648047
Informations de publication
Date de publication:
2022
2022
Historique:
received:
28
12
2021
accepted:
16
02
2022
entrez:
1
4
2022
pubmed:
2
4
2022
medline:
2
4
2022
Statut:
epublish
Résumé
Rheumatoid arthritis (RA) is a systemic inflammatory connective tissue disease that affects 1-2% of the population worldwide. Pulmonary manifestations including interstitial lung disease (ILD), airway disease, pleural and vascular disease can be seen in up to 30-40% of patients with RA, which are recognized as the second most frequent cause of death in RA patients. The simultaneous occurrence of COVID-19 in RA patients with or without ILD, and the similarities and differences between RA-related ILD and COVID-19 lung findings have been reported in the literature. However, there was no reported case on differentiation of clinical findings of a patient with RA exacerbation causing a new diagnosis of ILD during the pandemic conditions. Here, we presented a patient with RA who was misdiagnosed as COVID-19 twice due to non-specific respiratory symptoms and ground-glass opacities observed in high-resolution CT. The misdiagnosis led to a delayed diagnosis of ILD and prolonged pulmonary symptoms. Clinicians must critically review patients throughout the diagnostic workup by thinking other diseases besides COVID-19, particularly in the absence of a confirmatory result. The link between ILD or ILD exacerbation and COVID-19 remains to be determined. While research continues in the field, it is important to consider the importance of COVID-19 in cases of ILD exacerbation, and vice versa. Distinguishing lung imaging findings of COVID-19 from ILD is a major concern. Even though the primary manifestation of COVID-19 consists of respiratory symptoms, clinicians should be vigilant for other common conditions having the same symptoms. Clinicians should carefully distinguish a differential diagnosis between COVID-19 and a flare of rheumatic disease.
Sections du résumé
Background
UNASSIGNED
Rheumatoid arthritis (RA) is a systemic inflammatory connective tissue disease that affects 1-2% of the population worldwide. Pulmonary manifestations including interstitial lung disease (ILD), airway disease, pleural and vascular disease can be seen in up to 30-40% of patients with RA, which are recognized as the second most frequent cause of death in RA patients. The simultaneous occurrence of COVID-19 in RA patients with or without ILD, and the similarities and differences between RA-related ILD and COVID-19 lung findings have been reported in the literature. However, there was no reported case on differentiation of clinical findings of a patient with RA exacerbation causing a new diagnosis of ILD during the pandemic conditions.
Case Presentation
UNASSIGNED
Here, we presented a patient with RA who was misdiagnosed as COVID-19 twice due to non-specific respiratory symptoms and ground-glass opacities observed in high-resolution CT. The misdiagnosis led to a delayed diagnosis of ILD and prolonged pulmonary symptoms.
Discussion
UNASSIGNED
Clinicians must critically review patients throughout the diagnostic workup by thinking other diseases besides COVID-19, particularly in the absence of a confirmatory result. The link between ILD or ILD exacerbation and COVID-19 remains to be determined. While research continues in the field, it is important to consider the importance of COVID-19 in cases of ILD exacerbation, and vice versa.
Conclusion
UNASSIGNED
Distinguishing lung imaging findings of COVID-19 from ILD is a major concern. Even though the primary manifestation of COVID-19 consists of respiratory symptoms, clinicians should be vigilant for other common conditions having the same symptoms. Clinicians should carefully distinguish a differential diagnosis between COVID-19 and a flare of rheumatic disease.
Identifiants
pubmed: 35360748
doi: 10.3389/fmed.2022.844609
pmc: PMC8960299
doi:
Types de publication
Case Reports
Langues
eng
Pagination
844609Informations de copyright
Copyright © 2022 Torun and Karaman.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Pol J Radiol. 2021 Mar 12;86:e157-e158
pubmed: 33828626
Am J Med Sci. 2021 Jan;361(1):126-129
pubmed: 32912600
Biomed Res Int. 2017;2017:7915340
pubmed: 29238722
Ir J Med Sci. 2022 Feb;191(1):1-5
pubmed: 33564974
Turk Thorac J. 2021 Jul;22(4):346-352
pubmed: 35110253
JACC Case Rep. 2020 Aug;2(10):1614-1619
pubmed: 32342051
Maedica (Bucur). 2010 Dec;5(4):286-91
pubmed: 21977172
Ann Rheum Dis. 2020 Aug;79(8):1007-1013
pubmed: 32444415
J Hosp Med. 2020 Jun;15(6):363-366
pubmed: 32490798
Radiology. 2020 Sep;296(3):E145-E155
pubmed: 32301646